Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: Emphasis on its relevance to hepatitis

Transfusion

Volumn 40, Issue 5, 2000, Pages 596-601

  Wang, Jin Town ^a   Lee, C Z ^b   Kao, J H ^b   Sheu, J C ^b   Wang, T H ^b   Chen, D S ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; HEART SURGERY; HEPATITIS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; TORQUE TENO VIRUS; VIRUS INFECTION;

ADULT; ALANINE TRANSAMINASE; BLOOD TRANSFUSION; DNA VIRUS INFECTIONS; DNA VIRUSES; DNA, VIRAL; FEMALE; FLAVIVIRIDAE; HEPACIVIRUS; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; TAIWAN; TIME FACTORS;

EID: 0034081608     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40050596.x     Document Type: Article

References (23)

1. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of posttransfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Lancet 1991;338:1040-1.
2. Donahue JG, Munoz A, Ness PM, et al. The declining risk of posttransfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
3. Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
4. Okamoto H, Nishizawa T, Kato N, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttranfusion hepatitis of unknown etiology. Hepatol Res 1998;10:1-16.
5. Simmonds P, Davidson F, Lycett C, et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998;352:191-5.
6. Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998;352:195-7.
7. Wang TH, Wang JT, Lin JT, et al. A prospective study of posttransfusion hepatitis in Taiwan. J Hepatol 1991;13:38-43.
8. Wang JT, Wang TH, Sheu JC, et al. Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 1992;103:609-16.
9. Wang JT, Lin MT, Chen PJ, et al. Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: a true risk and occasional coinfection with hepatitis C virus shown in a prospective study. Blood 1994;84:934-40.
10. Wang JT, Tsai FT, Lee CZ, et al. A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996;88:1881-6.
11. Wang JT, Wang TH, Sheu JC, et al. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 1992;30:750-3.
12. Wang JT, Wang TH, Sheu JC, et al. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991;163:397-9.
13. Kao JH, Chen PJ, Lai MY, et al. Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections. Arch Virol 1998;143:797-802.
14. Sayers MH. Transfusion-transmitted viral infections other than hepatitis and human immunodeficiency virus infection. Cytomegalovirus, Epstein-Barr virus, human herpes-virus 6, and human parvovirus B19. Arch Pathol Lab Med 1994;118:346-9.
15. Wylie BR. Transfusion transmitted infection: viral and exotic disease. Anaesth Intensive Care 1993;21:24-30.
16. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-9.
17. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
18. Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336:741-6.
19. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336:747-54.
20. Wang JT, Chen PJ, Liu DP, et al. Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan. Transfusion 1998;38:290-5.
21. Brown KE, Green SW, Antunez de Mayolo J, et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994;343:895-6.
22. Tokudome S, Tokunaga O, Shimamoto Y, et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotrophic virus type I carriers in Saga, Japan. Cancer Res 1989;49:226-8.
23. Hjelle B. Human T-cell leukemia/lymphoma viruses. Life cycle, pathogenicity, epidemiology, and diagnosis. Arch Pathol Lab Med 1991;115:440-50.